Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults.

Palma, Paolo; Romiti, Maria Luisa; Bernardi, Stefania; Pontrelli, Giuseppe; Mora, Nadia; Santilli, Veronica; Tchidjou, Hyppolite Kuekou; Aquilani, Angela; Cotugno, Nicola; Alghisi, Federico; Lucidi, Vincenzina; Rossi, Paolo; Douagi, Iyadh

Palma, Paolo; Romiti, Maria Luisa; Bernardi, Stefania; Pontrelli, Giuseppe; Mora, Nadia; Santilli, Veronica; Tchidjou, Hyppolite Kuekou; Aquilani, Angela; Cotugno, Nicola; Alghisi, Federico; Lucidi, Vincenzina; Rossi, Paolo; Douagi, Iyadh.

Affiliation

Palma P; University Department of Pediatrics, DPUO, Clinical Trial Center Unit, Bambino Gesù Children's Hospital, Piazza S, Onofrio 4, 00165 Rome, Italy. paolo.palma@opbg.net

Biologicals ; 40(2): 134-9, 2012 Mar.

Article in En | MEDLINE | ID: mdl-22261282

Subject(s)

HIV Infections/immunology; Influenza A Virus, H1N1 Subtype/immunology; Influenza Vaccines/administration & dosage; Adjuvants, Immunologic/administration & dosage; Adolescent; Adult; Antibodies, Viral/blood; Child; Child, Preschool; Dose-Response Relationship, Immunologic; Female; HIV Infections/complications; Humans; Immunization Schedule; Influenza Vaccines/adverse effects; Influenza Vaccines/immunology; Influenza, Human/complications; Influenza, Human/immunology; Influenza, Human/prevention & control; Male; Polysorbates/administration & dosage; Prospective Studies; Safety; Squalene/administration & dosage; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Influenza Vaccines / HIV Infections / Influenza A Virus, H1N1 Subtype Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google